Intra-Uterine Contraceptive Devices (IUCD) Market Share, Size, Trends and Revenue Models 2021

29/gen/2018 11:54:14 Research Cosmos Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

In this region, global intra-uterine contraceptive devices market is projected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024.

 

Based on geography, the Global Intra-Uterine Contraceptive Devices (IUCD) Market is segmented into 5 geographical regions, such as,

North America,

South America,

Europe,

APAC,

MEA,

Rest of the World

 

Explore More Information about report @ https://www.researchcosmos.com/reports/iucd-market-analysis-global-industry-outlook-and-forecast-2017-to-2024/1731619905

 

Global intra-uterine contraceptive devices (IUCD) market competition by top players including -

 

Bayer AG dominated the IUCD market accounting largest market share followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. along with others such as include

DKT International,

Egemen International,

Melbea AG,

Ocon Medical Ltd.,

Pregna International Limited,

Medical Engineering Corporation SA,

SMB Corporation and Meril Life Sciences Pvt. Ltd.,

Medu Scientific Ltd, China RH Contraceptives Co., Ltd,

Sanghai Jolly Medical Education Co., Ltd,

Bernstein Leibhard LLP,

Zheijang Daji Medical Instruments, Ltd.,

Nimble International,

AME Line, Technico,

Cepeo,

Contraceptivos,

Injeflex Ind and Com Ltda,

Bersil,

Amed.

 

Request free sample @ https://www.researchcosmos.com/request/1731619905

 

The global intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/1731619905

 

The global intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

 

On the basis of end users the market is segmented into hospitals, gynecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

 

Check for discount @ https://www.researchcosmos.com/discount/1731619905

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on the globe. We are associated with world renowned publishers who when combined, serve hundreds of companies that publish and cover a wide range of insights.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line : +1 888 709 8757

Mail: dani@researchcosmos.com  

 

www.researchcosmos.com

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl